Levobupivacaine versus racemic bupivacaine for extradural anesthesia for cesarean delivery

Journal of the Medical Association of Thailand

Volumn 88, Issue 11, 2005, Pages 1563-1568

  Ngamprasertwong, Pornswan ^a   Udomtecha, Danai ^a   Charuluxananan, Somrat ^a   Rodanant, Oraluxana ^a   Srihatajati, Chaiwat ^a   Baogham, Sintichai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cesarean delivery; Extradural; Levobupivacaine; Local anesthetics; Obstetrics; Regional anesthesia

Indexed keywords

BUPIVACAINE; LEVOBUPIVACAINE; DRUG DERIVATIVE; LOCAL ANESTHETIC AGENT;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EPIDURAL ANESTHESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; ELECTIVE SURGERY; EPIDURAL DRUG ADMINISTRATION; METHODOLOGY; NERVE BLOCK; OBSTETRIC ANESTHESIA; POSTOPERATIVE PAIN; PREGNANCY; SAFETY; TREATMENT OUTCOME;

ADULT; ANESTHESIA, OBSTETRICAL; ANESTHETICS, LOCAL; BUPIVACAINE; CESAREAN SECTION; FEMALE; HUMANS; INJECTIONS, EPIDURAL; NERVE BLOCK; PAIN, POSTOPERATIVE; PREGNANCY; SAFETY; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 33645234907     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Af Ekenstam B, Egner B, Pettersson G. N-alkyl pyrrolidine and N-alkyl piperidine carboxylic acid amides. Acta Chem Scand 1957; 11: 1183-90.
2. Aberg G. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol Toxicol 1972; 31: 273-86.
3. Luduena FP, Bogado EF, Tullar BF. Optical isomers of mepivacaine and bupivacaine. Arch Int Pharmacodyn 1972; 200: 359-69.
4. Huang YF, Pryor ME, Mather LE, Veering BT. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998; 86: 797-804.
5. Gristwood O, Bardsley H, Baker H, Dickens J. Reduced cardiotoxicity of levobupivacaine compared with racemic bupivacaine (marcaine): new clinical evidence. Exp Opin Invest Drugs 1994; 3: 1209-12.
6. Morrison SG, Dominguez JJ, Frascarolo P, Reiz S. A comparison of the electrocardio graphic cardiotoxic effects of racemic bupivacaine, levobupivacaine, and ropivacaine in anesthetized swine. Anesth Analg 2000; 90: 1308-14.
7. Burm AGL, Van der Meer AD, Van Kleef JW, Zeiman PWM, Groen K. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. Br J Clin Pharmacol 1994; 38: 125-9.
8. Kopacz DJ, Allen HW. Accidental intravenous levobupivacaine. Anesth Analg 1999; 89: 1027-9.
9. Burke D, Henderson DJ, Simpson A, Faccenda KA, Morrison LMM, Bannister J, et al. A comparison of 0.25% S(-)-bupivacaine with 0.25% racemic bupivacaine for extradural analgesia in labour. Br J Anaesth 1999; 83: 750-9.
10. Cox CR, Faccenda KA, Gilhooly C, Bannister J, Scoth NB, Morrison LMM. Extradural S(-)-bupivacaine: a comparison with racemic RS-bupivacaine. Br J Anaesth 1998; 80: 289-93.
11. Bader AM, Lawrence CT, Camann WR, Nephew E, Datta S. Clinical effects and maternal and fetal plasma concentrations of 0.5% epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology 1999; 90: 1596-601.
12. Faccenda KA, Simpson AM, Henderson DJ, Smith D, McGrady EM, Morrison LMM. A comparison of levobupivacaine 0.5% and racemic bupivacaine 0.5% for extradural anesthesia for cesarean section. Reg Anesth Pain Med 2003; 28: 394-400.